Detalles de la búsqueda
1.
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.
World J Urol
; 40(11): 2609-2615, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083316
2.
Evaluation of maintenance treatment with PARP inhibitors in ovarian carcinoma patients responding to platinum therapy: Use of restricted mean survival time as an index of efficacy.
Int J Clin Pharmacol Ther
; 60(1): 32-35, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779394
3.
Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe.
Int J Technol Assess Health Care
; 37: e29, 2020 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33280625
4.
Trastuzumab biosimilar in metastatic breast cancer: Evaluating equivalence with originator using network meta-analysisâ©.
Int J Clin Pharmacol Ther
; 57(3): 160-162, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30574866
5.
Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy.
Int J Clin Pharmacol Ther
; 60(8): 370-372, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35652551
6.
CAPACITY BUILDING IN AGENCIES FOR EFFICIENT AND EFFECTIVE HEALTH TECHNOLOGY ASSESSMENT.
Int J Technol Assess Health Care
; 32(4): 292-299, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27745567
7.
Tisagenlecleucel in Non-Hodgkin Lymphoma: The Restricted Mean Survival Time as a Tool for Estimating Progression-Free Life Expectancy Better than the Median.
Acta Haematol
; 143(6): 598-599, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32074609
8.
Safety of intravitreal injections: Non-inferiority of bevacizumab compared with ranibizumab.
Int J Clin Pharmacol Ther
; 57(1): 41-42, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30369396
9.
Efficacy of deprescribing on health outcomes: An umbrella review of systematic reviews with meta-analysis of randomized controlled trials.
Ageing Res Rev
; 95: 102237, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367812
10.
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
Front Oncol
; 14: 1351995, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601759
11.
Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: the Improvement in Progression-Free Survival Is Small.
J Gastrointest Cancer
; 54(1): 9-10, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35040033
12.
Tislelizumab plus chemotherapy vs. pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials.
Chin Clin Oncol
; 12(5): 50, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817505
13.
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons.
Hematol Rep
; 15(4): 670-683, 2023 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38132276
14.
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient data.
Cancer Med
; 12(3): 2155-2165, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920297
15.
Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens.
Cancers (Basel)
; 15(7)2023 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046690
16.
Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments.
Hematol Rep
; 15(1): 57-65, 2023 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36648884
17.
Hospital Pharmacy Response to Covid-19 Pandemic in Italy: What We Learned From the First Outbreak Wave.
J Pharm Pract
; 36(1): 87-95, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34126804
18.
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses.
Cancers (Basel)
; 15(6)2023 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980518
19.
Rituximab biosimilar evaluated by network meta-analysis.
Haematologica
; 102(12): e497-e498, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935845
20.
Medical Therapy, Radiofrequency Ablation, or Cryoballoon Ablation as First-Line Treatment for Paroxysmal Atrial Fibrillation: Interpreting Efficacy Through the Shiny Method.
Cureus
; 14(2): e22645, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35237496